Cardiotoxicity and cancer therapy: Treatment-related cardiac morbidity in patients presenting with symptoms suggestive of heart or lung disease

Oncology (Switzerland)

Volumn 85, Issue 3, 2013, Pages 137-144

  Wieshammer, Siegfried ^a   Dreyhaupt, Jens ^b   Müller, Dirk ^a   Momm, Felix ^a   Jakob, Andreas ^a   Freund, Ulrich ^a  

^a Offenburg University   (Germany)

^b UNIVERSITY OF ULM   (Germany)

Author keywords

Anthracyclines; Cardiotoxicity; Chemotherapy; Heart disease; Natriuretic peptides; Radiotherapy

Indexed keywords

ALKYLATING AGENT; AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; ANTHRACYCLINE; ANTIANDROGEN; ANTINEOPLASTIC AGENT; AROMATASE INHIBITOR; GONADORELIN AGONIST; MICROTUBULE TARGETING DRUG; MOLECULAR TARGETING AGENT; RITUXIMAB; UNCLASSIFIED DRUG; ANTHRACYCLINE DERIVATIVE; ANTIMETABOLITE;

AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CARDIOTOXICITY; CLINICAL EXAMINATION; CLINICAL TRIAL; FEMALE; HEART DISEASE; HEART INJURY; HORMONAL THERAPY; HUMAN; LUNG DISEASE; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; CANCER THERAPY; CONTROLLED STUDY;

AGED; ANTHRACYCLINES; ANTINEOPLASTIC AGENTS; BIOLOGICAL MARKERS; ECHOCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; GERMANY; HEART DISEASES; HEART VENTRICLES; HUMANS; LUNG DISEASES; MALE; NATRIURETIC PEPTIDE, BRAIN; NEOPLASMS; ODDS RATIO; ORGANS AT RISK; PEPTIDE FRAGMENTS; PROSPECTIVE STUDIES; RADIATION DOSAGE; RADIATION INJURIES; RISK ASSESSMENT; RISK FACTORS; SENSITIVITY AND SPECIFICITY; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED; TROPONIN T;

EID: 84885671839     PISSN: 00302414     EISSN: 14230232     Source Type: Journal    
DOI: 10.1159/000354299     Document Type: Article

References (21)

1. Albini A, Pennesi G, Donatelli F, Cammarota R, De Flora S, Noonan DM: Cardiotoxicity of anticancer drugs: the need for cardio-oncology and cardio-oncological prevention. J Natl Cancer Inst 2010; 102: 14-25
2. Altena R, Perik PJ, van Veldhuisen DJ, de Vries EG, Gietema JA: Cardiovascular toxicity caused by cancer treatment: strategies for early detection. Lancet Oncol 2009; 10: 391-399
3. Mann DL, Krone RJ: Cardiac disease in cancer patients: An overview. Prog Cardiovasc Dis 2010; 53: 80-87
4. Adams MJ, Lipsitz SR, Colan SD, Tarbell NJ, Treves ST, Diller L, Greenbaum N, Mauch P, Lipshultz SE: Cardiovascular status in longterm survivors of Hodgkin?s disease treated with chest radiotherapy. J Clin Oncol 2004; 22: 3139-3148
5. Heidenreich PA, Schnittger I, Strauss HW, Vagelos RH, Lee BK, Mariscal CS, Tate DJ, Horning SJ, Hoppe RT, Hancock SL: Screening for coronary artery disease after mediastinal irradiation for Hodgkin?s disease. J Clin Oncol 2007; 25: 43-49, erratum p 1635
6. Chargari C, Kirov KM, Bollet MA, Magné N, Védrine L, Cremades S, Beuzeboc P, Fourquet A, Kirova YM: Cardiac toxicity in breast cancer patients: from a fractional point of view to a global assessment. Cancer Treat Rev 2011; 37: 321-330
7. Jones LW, Haykowsky MJ, Swartz JJ, Douglas PS, Mackey JR: Early breast cancer therapy and cardiovascular injury. J Am Coll Cardiol 2007; 50: 1435-1441
8. Wieshammer S, Dreyhaupt J, Basler B, Marsovszky E: NT-proBNP for pulmonologists: not only a rule-out test for systolic heart failure but also a global marker of heart disease. Respiration 2009; 77: 370-380
9. Levey AS, Coresh J, Greene T, Marsh J, Stevens LA, Kusek JW, van Lente F, Chronic Kidney Disease Epidemiology Collaboration: Expressing the Modification of Diet in Renal Disease Study equation for estimating glomerular filtration rate with standardized serum creatinine values. Clin Chem 2007; 53: 766-772
10. Kurella Tamura M, Xie D, Yaffe K, Cohen DL, Teal V, Kasner SE, Messé SR, Sehgal AR, Kusek J, DeSalvo KB, Cornish-Zirker D, Cohan J, Seliger SL, Chertow GM, Go AS: Vascular risk factors and cognitive impairment in chronic kidney disease: the Chronic Renal Insufficiency Cohort (CRIC) study. Clin J Am Soc Nephrol 2011; 6: 248-256
11. Jain M, Townsend RR: Chemotherapy agents and hypertension: a focus on angiogenesis blockade. Curr Hypertens Rep 2007; 9: 320-328
12. van den Belt-Dusebout AW, Nuver J, de Wit R, Gietema JA, ten Bokkel Huinink WW, Rodrigus PT, Schimmel EC, Aleman BM, van Leeuwen FE: Long-term risk of cardiovascular disease in 5-year survivors of testicular cancer. J Clin Oncol 2006; 24: 467-475
13. Prosnitz RG, Hubbs JL, Evans ES, Zhou SM, Yu X, Blazing MA, Hollis DR, Tisch A, Wong TZ, Borges-Neto S, Hardenbergh PH, Marks LB: Prospective assessment of radiotherapy- associated cardiac toxicity in breast cancer patients: Analysis of data 3 to 6 years after treatment. Cancer 2007; 110: 1840-1850
14. Darby SC, Ewertz M, McGale P, Bennet AM, Blom-Goldman U, Brønnum D, Correa C, Cutter D, Gagliardi G, Gigante B, Jensen MB, Nisbet A, Peto R, Rahimi K, Taylor C, Hall P: Risk of ischemic heart disease in women after radiotherapy for breast cancer. N Engl J Med 2013; 368: 987-998
15. Heidenreich PA, Hancock SL, Vagelos RH, Lee BK, Schnittger I: Diastolic dysfunction after mediastinal irradiation. Am Heart J 2005; 150: 977-982
16. Senkus-Konefka E, Jassem J: Cardiovascular effects of breast cancer radiotherapy. Cancer Treat Rev 2007; 33: 578-593
17. Bouillon K, Haddy N, Delaloge S, Garbay JR, Garsi JP, Brindel P, Mousannif A, Lê MG, Labbe M, Arriagada R, Jougla E, Chavaudra J, Diallo I, Rubino C, de Vathaire F: Long-term cardiovascular mortality after radiotherapy for breast cancer. J Am Coll Cardiol 2011; 57: 445-452
18. Mueller C, Breidthardt T, Laule-Kilian K, Christ M, Perruchoud AP: The integration of BNP and NT-proBNP into clinical medicine. Swiss Med Wkly 2007; 137: 4-12
19. Fallah-Rad N, Walker JR, Wassef A, Lytwyn M, Bohonis S, Fang T, Tian G, Kirkpatrick ID, Singal PK, Krahn M, Grenier D, Jassal DS: The utility of cardiac biomarkers, tissue velocity and strain imaging, and cardiac magnetic resonance imaging in predicting early left ventricular dysfunction in patients with human epidermal growth factor receptor IIpositive breast cancer treated with adjuvant trastuzumab therapy. J Am Coll Cardiol 2011; 57: 2263-2270
20. Sawaya H, Sebag IA, Plana JC, Januzzi JL, Ky B, Cohen V, Gosavi S, Carver JR, Wiegers SE, Martin RP, Picard MH, Gerszten RE, Halpern EF, Passeri J, Kuter I, Scherrer-Crosbie M: Early detection and prediction of cardiotoxicity in chemotherapytreated patients. Am J Cardiol 2011; 107: 1375-1380
21. Cardinale D, Cipolla CM: Assessment of cardiotoxicity with cardiac biomarkers in cancer patients. Herz 2011; 36: 325-332